Acuta Capital Partners, LLC Rocket Pharmaceuticals, Inc. Transaction History
Acuta Capital Partners, LLC
- $122 Million
- Q1 2024
A detailed history of Acuta Capital Partners, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 326,787 shares of RCKT stock, worth $7.04 Million. This represents 7.2% of its overall portfolio holdings.
Number of Shares
326,787
Previous 366,015
10.72%
Holding current value
$7.04 Million
Previous $11 Million
19.75%
% of portfolio
7.2%
Previous 8.55%
Shares
10 transactions
Others Institutions Holding RCKT
# of Institutions
205Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$381 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$197 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$128 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$116 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$90.3 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.63B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...